Search

Your search keyword '"Christine Gstrein"' showing total 2 results
Start Over Author "Christine Gstrein" Topic 2705 cardiology and cardiovascular medicine
2 results on '"Christine Gstrein"'

1. A giant right-sided heart due to idiopathic pulmonary hypertension

Author

Thomas F. Lüscher, Christine Gstrein, Jelena-R. Ghadri, Christian Templin, University of Zurich, and Templin, Christian

Subjects
Male, medicine.medical_specialty, Hypertrophy, Right Ventricular, business.industry, Idiopathic Pulmonary Hypertension, Right sided heart, Hypertension, Pulmonary, 610 Medicine & health, Middle Aged, 2705 Cardiology and Cardiovascular Medicine, Tricuspid Valve Insufficiency, Pulmonary Heart Disease, Internal medicine, 10209 Clinic for Cardiology, Emergency Medicine, medicine, Cardiology, 2741 Radiology, Nuclear Medicine and Imaging, Humans, Radiology, Nuclear Medicine and imaging, 2711 Emergency Medicine, Cardiology and Cardiovascular Medicine, business
Published
2013

2. Two-year outcomes after percutaneous mitral valve repair with the MitraClip system: durability of the procedure and predictors of outcome

Author

Christine Gstrein, Giovanni Pedrazzini, Iveta Petrova-Slater, Jürg Grünenfelder, Elena Pasotti, Peiman Jamshidi, Paul Erne, Francesco Faletra, Roberto Corti, Thomas F. Lüscher, Oliver Gaemperli, Michel Zuber, Tiziano Moccetti, Patric Biaggi, Stefan Toggweiler, Daniel Sürder, and University of Zurich

Subjects
COPD, medicine.medical_specialty, Mitral regurgitation, Interventional cardiology, medicine.drug_class, business.industry, MitraClip, Pulmonary disease, 610 Medicine & health, medicine.disease, 11171 Cardiocentro Ticino, 2705 Cardiology and Cardiovascular Medicine, VALVULAR DISEASE, Surgery, Valvular Heart Disease, INTERVENTIONAL CARDIOLOGY, 10209 Clinic for Cardiology, medicine, Natriuretic peptide, Cardiology and Cardiovascular Medicine, business, Percutaneous Mitral Valve Repair, Kidney disease
Abstract

Objective Analyse 2-year outcomes after MitraClip therapy and identify predictors of outcome. Methods Consecutive patients (n=74) undergoing MitraClip therapy were included in the MitraSWISS registry and followed prospectively. Results A reduction of mitral regurgitation (MR) to ≤ mild was achieved in 32 (43%) patients and to moderate in 31 (42%) patients; 16/63 (25%) patients with initially successful treatment developed recurrent moderate to severe or severe MR during the first year and only 1 patient did so during the second year. At 2 years, moderate or less MR was more frequently present in patients with a transmitral mean gradient

Published
2014
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results